Apollo Gleneagles Hospitals in their effort to increase awareness about the advantages of Robotic Surgery as a better treatment for various cancers, organised an interactive session with world renowned urologist Prokar Dasgupta who shared his expertise and insights on the advancement of robotics globally.

A noted authority in academic urology for the past seven years within the Division of Immunology, Infection and Inflammatory Diseases (DIIID), Guy’s Hospital, King’s College London School of Medicine, Prokar Dasgupta has pioneered modern robotic urological surgery in UK, following in the footsteps of John Wickham.

His team is recognised internationally for the Guy’s robotic cystoprostatectomy technique for bladder cancer and is the leading European group amongst the International Robotic Cystectomy Consortium (IRCC).

He conducted the first randomised controlled trial of robotic urology in collaboration with Johns Hopkins Hospital. A further innovation is the description of a minimally invasive method of delivering Botulinum toxin to refractory overactive bladders (Dasgupta technique). He is the Urological Foundation Mentor in Robotic Surgery.

“Robotic surgery has a lot to offer to prostate cancer patients,” said Dasgupta. “It is more precise, minimally invasive, heals faster and has the best clinical outcomes for treatment of these Cancers. In the hands of highly experienced surgeons, patients are seeing very positive results. I have seen over the past couple of years that the ability to treat and counsel patients have significantly improved with robotic surgery because of its accuracy and results it yields post-surgery. With a robotic prostatectomy, the benefits include a high prostate cancer cure rate and reduced urinary continence and impotence.”

Speaking on the occasion Sujoy Kar, Director Medical Services, Apollo GleneaglesHospitals, Kolkata, said, “We at Apollo Gleneagles Hospitals have undertaken this initiative with the purpose of establishing Robotic Surgery as the unsurpassed and most definite method of treating certain cancers.Robotic surgery is highly beneficial for the patient because they have a shorter hospital stay and very little pain and this is the same for the whole spectrum of patients. We are glad to have Prof Prokar Dasgupta with us as Honorary Director in the department of Robotic Surgery and he will help us design the best studies for more accurate and reliable results in the field of robotic surgery.”